Postoperative pain management in obstetric anesthesia-new challenges and solutions

Journal of Clinical Anesthesia

Volumn 16, Issue 1, 2004, Pages 57-65

  Leung, Albert Y ^a  

^a University of California   (United States)

Author keywords

Anesthesia; Obstetrical; Pain physiology; Postpartum period

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BUPIVACAINE; CHLOROPROCAINE; CLONIDINE; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; LEVOBUPIVACAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORPROPOXYPHENE; OPIATE; OXYCODONE; PARACETAMOL; PETHIDINE; PIROXICAM; ROPIVACAINE; SUFENTANIL; TRAMADOL;

ACUPUNCTURE; BREAST FEEDING; CARDIOTOXICITY; CLINICAL TRIAL; DROWSINESS; EDITORIAL; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; NAUSEA; NEPHROTOXICITY; NERVE STIMULATION; OBSTETRIC ANESTHESIA; PATHOPHYSIOLOGY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PUERPERIUM; RESPIRATION DEPRESSION; VOMITING;

EID: 1342279461     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2003.02.012     Document Type: Review

References (130)

1. Cousins M.J., John J. Bonica distinguished lecture. Acute pain and the injury response immediate and prolonged effects . Reg Anesth. 14:1998;162-179.
2. Hua X.Y., Chen P., Polgar E., et al. Spinal neurokinin NK1 receptor down-regulation and antinociception effects of spinal NK1 receptor antisense oligonucleotides and NK1 receptor occupancy . J Neurochem. 70:1998;688-698.
3. Raja S.N., Meyer R.A., Campbell J.N. Peripheral mechanisms of somatic pain. Anesthesiology. 68:1988;571-590.
4. Dirig D.M., Yaksh T.L. In vitro prostanoid release from spinal cord following peripheral inflammation effects of substance P, NMDA and capsaicin . Br J Pharmacol. 126:1999;1333-1340.
5. Dirig D.M., Yaksh T.L. Spinal synthesis and release of prostanoids after peripheral injury and inflammation. Adv Exper Med Biol. 469:1999;401-408.
6. Yaksh T.L., Hua X.Y., Kalcheva I., Nozaki-Taguchi N., Marsala M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci USA. 96:1999;7680-7686.
7. Dougherty P.M., Willis W.D. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain. 47:1991;85-93.
8. Albe-Fessard D., Berkley K.J., Kruger L., Ralston H.J. 3rd, Willis W.D. Jr. Diencephalic mechanisms of pain sensation. Brain Res. 356:1985;217-296.
9. Bowker R.M., Westlund K.N., Coulter J.D. Serotonergic projections to the spinal cord from the midbrain in the rat an immunocytochemical and retrograde transport study . Neurosci Lett. 24:1981;221-226.
10. Westlund K.N., Bowker R.M., Ziegler M.G., Coulter J.D. Origins and terminations of descending noradrenergic projections to the spinal cord of monkey. Brain Res. 292:1984;1-16.
11. Yaksh TL: Regulation of spinal nociceptive processing: where we went when we wandered onto the path marked by the gate. Pain 1999;(Suppl 6S):149-52
12. Vasko M.R. Prostaglandin-induced neuropeptide release from spinal cord. Prog Brain Res. 104:1995;367-380.
13. Joris J. Efficacy of nonsteroidal antiinflammatory drugs in postoperative pain. Acta Anaesthesiol Belg. 47:1996;115-123.
14. Sunshine A., Zighelboim I., Laska E., Siegel C., Olson N.Z., De Castro A. A double-blind, parallel comparison of ketoprofen, aspirin, and placebo in patients with postpartum pain. J Clin Pharmacol. 26:1986;706-711.
15. Barst R.J., Gersony W.M. The pharmacological treatment of patent ductus arteriosus. A review of the evidence. Drugs. 38:1989;249-266.
16. Bloomfield S.S., Mitchell J., Cissell G.B., Barden T.P., Yee J.P. Ketorolac versus aspirin for postpartum uterine pain. Pharmacotherapy. 6:1986;247-252.
17. Tzeng J.I., Mok M.S. Combination of intramuscular Ketorolac and low dose epidural morphine for the relief of post-caesarean pain. Ann Acad Med Singapore. 23:1994;10-13.
18. Catapano M.S. The analgesic efficacy of ketorolac for acute pain. J Emerg Med. 14:1996;67-75.
19. Wheatley R.G. Analgesic efficacy of ketorolac. Acta Anaesthesiol Belg. 47:1996;135-142.
20. Camu F., Lauwers M.H., Vanlersberghe C. Side effects of NSAIDs and dosing recommendations for ketorolac. Acta Anaesthesiol Belg. 47:1996;143-149.
21. Corelli R.L., Gericke K.R. Renal insufficiency associated with intramuscular administration of ketorolac tromethamine. Ann Pharmacother. 27:1993;1055-1057.
22. Fong J., Gora M.L. Reversible renal insufficiency following ketorolac therapy. Ann Pharmacother. 27:1993;510-512.
23. Gillis J.C., Brogden R.N. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs. 53:1997;139-188.
24. Lee A, Cooper MG, Craig JC, Knight JF, Keneally JP: Effects of nonsteroidal anti-inflammatory drugs on post-operative renal function in adults. Cochrane Database Syst Rev 2001;CD002765
25. Pearce C.J., Gonzalez F.M., Wallin J.D. Renal failure and hyperkalemia associated with ketorolac tromethamine. Arch Intern Med. 153:1993;1000-1002.
26. La Corte R., Caselli M., Castellino G., Bajocchi G., Trotta F. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders. Drug Saf. 20:1999;527-543.
27. Urban M.K. COX-2 specific inhibitors offer improved advantages over traditional NSAIDs. Orthopedics. 23:2000;S761-764.
28. Masferrer J.L., Isakson P.C., Seibert K. Cyclooxygenase-2 inhibitors a new class of anti-inflammatory agents that spare the gastrointestinal tract . Gastroenterol Clin North Am. 25:1996;363-372.
29. Silverstein F.E., Faich G., Goldstein J.L., et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study . JAMA. 284:2000;1247-1255.
30. Morrison B.W., Christensen S., Yuan W., Brown J., Amlani S., Seidenberg B. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain a randomized, controlled trial . Clin Ther. 21:1999;943-953.
31. Dahl V., Raeder J.C. Non-opioid postoperative analgesia. Acta Anaesthesiol Scand. 44:2000;1191-1203.
32. Mukherjee D., Nissen S.E., Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 286:2001;954-959.
33. Schnitzer T.J., Truitt K., Fleischmann R., et al. The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group. Clin Ther. 21:1999;1688-1702.
34. Lewis K.S., Han N.H. Tramadol a new centrally acting analgesic . Am J Health Sys Pharm. 54:1997;643-652.
35. Raffa R.B. A novel approach to the pharmacology of analgesics. Am J Med. 101:1996;40S-46S.
36. Shipton E.A. Tramadol-present and future. Anaesth Intensive Care. 28:2000;363-374.
37. Elbourne D, Wiseman RA: Types of intra-muscular opioids for maternal pain relief in labour. Cochrane Database Syst Rev 2000;CD001237
38. Desmeules J.A. The tramadol option. Eur J Pain. 4:(Suppl A):2000;15-21.
39. Aronson M.D. Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol contrasting therapies for the treatment of chronic pain . Clin Ther. 19:1997;420-432.
40. Bamigbade T.A., Langford R.M. Tramadol hydrochloride an overview of current use . Hosp Med. 59:1998;373-376.
41. Radbruch L., Grond S., Lehmann K.A. A risk-benefit assessment of tramadol in the management of pain. Drug Saf. 15:1996;8-29.
42. Lehmann K.A. Tramadol in acute pain. Drugs. 53:(Suppl 2):1997;25-33.
43. FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee. Teratology 1994;49:446-7
44. Addis A., Sharabi S., Bonati M. Risk classification systems for drug use during pregnancy are they a reliable source of information? Drug Saf. 23:2000;245-253.
45. Friedman J.M., Little B.B., Brent R.L., Cordero J.F., Hanson J.W., Shepard T.H. Potential human teratogenicity of frequently prescribed drugs. Obstet Gynecol. 75:1990;594-599.
46. Sannerstedt R., Lundborg P., Danielsson B.R., et al. Drugs during pregnancy an issue of risk classification and information to prescribers . Drug Saf. 14:1996;69-77.
47. Tverskoy M., Cozacov C., Ayache M., Bradley E.L. Jr, Kissin I. Postoperative pain after inguinal herniorrhaphy with different types of anesthesia. Anesth Analg. 70:1990;29-35.
48. Wittels B., Faure E.A., Chavez R., et al. Effective analgesia after bilateral tubal ligation. Anesth Analg. 87:1998;619-623.
49. Unnerstall J.R., Kopajtic T.A., Kuhar M.J. Distribution of alpha 2 agonist binding sites in the rat and human CNS analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents . Brain Res. 319:1984;69-101.
50. Filos K.S., Goudas L.C., Patroni O., Polyzou V. Intrathecal clonidine as a sole analgesic for pain relief after cesarean section. Anesthesiology. 77:1992;267-274.
51. De Kock M., Crochet B., Morimont C., Scholtes J.L. Intravenous or epidural clonidine for intra- and postoperative analgesia. Anesthesiology. 79:1993;525-531.
52. Bonnet F., Buisson V.B., Francois Y., Catoire P., Saada M. Effects of oral and subarachnoid clonidine on spinal anesthesia with bupivacaine. Reg Anesth. 15:1990;211-214.
53. Eisenach J.C., D'Angelo R., Taylor C., Hood D.D. An isobolographic study of epidural clonidine and fentanyl after cesarean section. Anesth Analg. 79:1994;285-290.
54. Yaksh T.L., Reddy S.V. Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology. 54:1981;451-467.
55. Liu S., Chiu A.A., Neal J.M., Carpenter R.L., Bainton B.G., Gerancher J.C. Oral clonidine prolongs lidocaine spinal anesthesia in human volunteers. Anesthesiology. 82:1995;1353-1359.
56. Singelyn F.J., Dangoisse M., Bartholomée S., Gouverneur J.M. Adding clonidine to mepivacaine prolongs the duration of anesthesia and analgesia after axillary brachial plexus block. Reg Anesth. 17:1992;148-150.
57. Maze M., Tranquilli W. Alpha-2 adrenoceptor agonists defining the role in clinical anesthesia . Anesthesiology. 74:1991;581-605.
58. Kanjhan R. Opioids and pain. Clin Exper Pharmacol Physiol. 22:1995;397-403.
59. Yaksh T.L. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol Scand. 41:(1 Pt 2):1997;94-111.
60. Palangio M., Wideman G.L., Keffer M., et al. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain. Clin Ther. 22:2000;600-612.
61. Mercadante S., Fulfaro F. Alternatives to oral opioids for cancer pain. Oncology. 13:1999;212-225.
62. Reddy S.K., Nguyen P. Breakthrough pain in cancer patients new therapeutic approaches to an old challenge . Curr Rev Pain. 4:2000;242-247.
63. Rhiner M, Kedziera P: Managing breakthrough cancer pain: a new approach. Home Healthc Nur 1999;17(6 Suppl):suppl 1-12; quiz 13-5
64. Rospond R.M. A new transmucosal fentanyl for breakthrough cancer pain. Cancer Prac. 7:1999;317-320.
65. Sinatra R., Chung K.S., Silverman D.G., et al. An evaluation of morphine and oxymorphone administered via patient-controlled analgesia (PCA) or PCA plus basal infusion in postcesarean-delivery patients. Anesthesiology. 71:1989;502-507.
66. Kussman B.D., Sethna N.F. Pethidine-associated seizure in a healthy adolescent receiving pethidine for postoperative pain control. Paediatr Anaesth. 8:1998;349-352.
67. Woodhouse A., Hobbes A.F., Mather L.E., Gibson M. A comparison of morphine, pethidine and fentanyl in the postsurgical patient-controlled analgesia environment. Pain. 64:1996;115-121.
68. Ballantyne J.C., Carr D.B., Chalmers T.C., Dear K.B., Angelillo I.F., Mosteller F. Postoperative patient-controlled analgesia meta-analyses of initial randomized control trials . J Clin Anesth. 5:1993;182-193.
69. Cousins M.J., Mather L.E. Intrathecal and epidural administration of opioids. Anesthesiology. 61:1984;276-310.
70. Gibbs C.P., Krischer J., Peckham B.M., Sharp H., Kirschbaum T.H. Obstetric anesthesia a national survey . Anesthesiology. 65:1986;298-306.
71. Halpern S.H., Arellano R., Preston R., et al. Epidural morphine vs hydromorphone in post-caesarean section patients. Can J Anaesth. 43:1996;595-598.
72. Vaughan D.J., Ahmad N., Lillywhite N.K., Lewis N., Thomas D., Robinson P.N. Choice of opioid for initiation of combined spinal epidural analgesia in labour-fentanyl or diamorphine. Br J Anaesth. 86:2001;567-569.
73. Hamber E.A., Viscomi C.M. Intrathecal lipophilic opioids as adjuncts to surgical spinal anesthesia. Reg Anesth Pain Med. 24:1999;255-263.
74. Ohmura S., Kawada M., Ohta T., Yamamoto K., Kobayashi T. Systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-infused rats. Anesth Analg. 93:2001;743-748.
75. Santos A.C., DeArmas P.I. Systemic toxicity of levobupivacaine, bupivacaine, and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes. Anesthesiology. 95:2001;1256-1264.
76. Wang R.D., Dangler L.A., Greengrass R.A. Update on ropivacaine. Expert Opin Pharmacother. 2:2001;2051-2063.
77. Bardsley H., Gristwood R., Baker H., Watson N., Nimmo W. A comparison of the cardiovascular effects of levobupivacaine and rac- bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol. 46:1998;245-249.
78. Foster R.H., Markham A. Levobupivacaine a review of its pharmacology and use as a local anaesthetic . Drugs. 59:2000;551-579.
79. Glaser C., Marhofer P., Zimpfer G., et al. Levobupivacaine versus racemic bupivacaine for spinal anesthesia. Anesth Analg. 94:2002;194-198.
80. Vercauteren M.P., Hans G., De Decker K., Adriaensen H.A. Levobupivacaine combined with sufentanil and epinephrine for intrathecal labor analgesia a comparison with racemic bupivacaine . Anesth Analg. 93:2001;996-1000.
81. Kafer E.R., Brown J.T., Scott D., et al. Biphasic depression of ventilatory responses to CO2 following epidural morphine. Anesthesiology. 58:1983;418-427.
82. Pan P.H., James C.F. Anesthetic-postoperative morphine regimens for cesarean section and postoperative oxygen saturation monitored by a telemetric pulse oximetry network for 24 continuous hours. J Clin Anesth. 6:1994;124-128.
83. Yaksh T.L., Provencher J.C., Rathbun M.L., Kohn F.R. Pharmacokinetics and efficacy of epidurally delivered sustained-release encapsulated morphine in dogs. Anesthesiology. 90:1999;1402-1412.
84. Flaatten H., Felthaus J., Larsen R., Bernhardsen S., Klausen H. Postural post-dural puncture headache after spinal and epidural anaesthesia. A randomised, double-blind study. Acta Anaesthesiol Scand. 42:1998;759-764.
85. Parnass S.M., Schmidt K.J. Adverse effects of spinal and epidural anaesthesia. Drug Saf. 5:1990;179-194.
86. Vandermeulen E, Gogarten W, Van Aken H: Risks and complications following peridural anesthesia. Anaesthesist 1997;46 (Suppl 3):S179-86
87. Shearer V.E., Jhaveri H.S., Cunningham F.G. Puerperal seizures after post-dural puncture headache. Obstet Gynecol. 85:1995;255-260.
88. Echevarría Moreno M., Caba Barrientos F.J., Martínez Diestre D., et al. Incidence of post-dural puncture headache using the 24G "pencil tip" needle. Prospective study in 100 young patients. Rev Esp Anestesiol Reanim. 38:1991;370-372.
89. Harrison D.A., Langham B.T. Post-dural puncture headache a comparison of the Sprotte and Yale needles in urological surgery . Eur J Anaesthesiol. 11:1994;325-327.
90. Hwang J.J., Ho S.T., Wang J.J., Liu H.S. Post dural puncture headache in cesarean section comparison of 25-gauge Whitacre with 25- and 26-gauge Quincke needles . Acta Anaesthesiol Sin. 35:1997;33-37.
91. Lim M., Cross G.D., Sold M. Postspinal headache. A comparison of the 24G Sprotte syringe and a 29G Quincke needle. Anaesthesist. 41:1992;539-543.
92. Ross B.K., Chadwick H.S., Mancuso J.J., Benedetti C. Sprotte needle for obstetric anesthesia decreased incidence of post dural puncture headache . Reg Anesth. 17:1992;29-33.
93. Wu Y.W., Hui Y.L., Tan P.P. Incidence of post-dural puncture headache with 25-gauge Quincke spinal needle. Ma Zui Xue Za Zhi. 29:1991;538-541.
94. Dunbar S.A., Katz N.P. Post-dural puncture thoracic pain without headache relief with epidural blood patch . Can J Anaesth. 42:1995;221-223.
95. Leibold R.A., Yealy D.M., Coppola M., Cantees K.K. Post-dural-puncture headache characteristics, management, and prevention . Ann Emerg Med. 22:1993;1863-1870.
96. Yücel A., Ozyalçin S., Talu G.K., Yücel E.C., Erdine S. Intravenous administration of caffeine sodium benzoate for postdural puncture headache. Reg Anesth Pain Med. 24:1999;51-54.
97. Buggy D., MacEvilly M. Do epidurals cause back pain? Br J Hosp Med. 56:1996;99-101.
98. Durbridge J., Holdcroft A. The long-term effects of analgesia in labour. Baillieres Clin Obstet Gynaecol. 12:1998;485-498.
99. Golub M.S. Labor analgesia and infant brain development. Pharmacol Biochem Behav. 55:1996;619-628.
100. Wittels B., Scott D.T., Sinatra R.S. Exogenous opioids in human breast milk and acute neonatal neurobehavior a preliminary study . Anesthesiology. 73:1990;864-869.
101. Halpern S.H., Levine T., Wilson D.B., MacDonell J., Katsiris S.E., Leighton B.L. Effect of labor analgesia on breastfeeding success. Birth. 26:1999;83-88.
102. Scherer R., Holzgreve W. Influence of epidural analgesia on fetal and neonatal well-being. Eur J Obstet Gynecol Reprod Biol. 59:(Suppl):1995;S17-29.
103. Evron S., Schenker J.G., Olshwang D., Granat M., Magora F. Postoperative analgesia by percutaneous electrical stimulation in gynecology and obstetrics. Eur J Obstet Gynecol Reprod Biol. 12:1981;305-313.
104. Ernst E., Pittler M.H. The effectiveness of acupuncture in treating acute dental pain a systematic review . Br Dent J. 184:1998;443-447.
105. Han J.S., Terenius L. Neurochemical basis of acupuncture analgesia. Annu Rev Pharmacol Toxicol. 22:1982;193-220.
106. Hui K.K., Liu J., Makris N., et al. Acupuncture modulates the limbic system and subcortical gray structures of the human brain evidence from fMRI studies in normal subjects . Hum Brain Mapp. 9:2000;13-25.
107. Liu X., Zhu B., Zhang S.X. Relationship between electroacupuncture analgesia and descending pain inhibitory mechanism of nucleus raphe magnus. Pain. 24:1986;383-396.
108. Chez R.A., Jonas W.B. Complementary and alternative medicine. Part I Clinical studies in obstetrics . Obstet Gynecol Surv. 52:1997;704-708.
109. Umeh B.U. Sacral acupuncture for pain relief in labour initial clinical experience in Nigerian women . Acupunc Electrother Res. 11:1986;147-151.
110. Lehmann K.A., Gerhard A., Horrichs-Haermeyer G., Grond S., Zech D. Postoperative patient-controlled analgesia with sufentanil analgesic efficacy and minimum effective concentrations . Acta Anaesthesiol Scand. 35:1991;221-226.
111. Lubenow T.R., Ivankovieh A.D. Management of acute postoperative pain. Barash P.G., Cullen B.F., Stoelting R.K. Clinical Anesthesia. 2nd ed :1992;1559 JB Lippincott, Philadelphia.
112. Notarianni L.J., Oldham H.G., Bennett P.N. Passage of paracetamol into breast milk and its subsequent metabolism by the neonate. Br J Clin Pharmacol. 24:1987;63-67.
113. Bitzen P.O., Gustafsson B., Jostell K.G., Melander A., Wahlin-Boll E. Excretion of paracetamol in human breast milk. Eur J Clin Pharmacol. 20:1981;123-125.
114. Berlin C.M. Jr, Yaffe S.J., Ragni M. Disposition of acetaminophen in milk, saliva, and plasma of lactating women. Pediatr Pharmacol. 1:1980;135-141.
115. Findlay J.W., DeAngelis R.L., Kearney M.F., Welch R.M., Findlay J.M. Analgesic drugs in milk and plasma. Clin Pharmacol Ther. 29:1981;625-633.
116. Townsend R.J., Benedetti T.J., Erickson S.H., et al. Excretion of ibuprofen into breast milk. Am J Obstet Gynecol. 149:1984;184-186.
117. Weibert R.T., Townsend R.J., Kaiser D.G., Naylor A.J. Lack of ibuprofen secretion into human milk. Clin Pharmacol. 1:1982;457-458.
118. Walter K., Dilger C. Ibuprofen in human milk. Br J Clin Pharmacol. 44:1997;211-212.
119. Lebedes T.H., Wojnar-Horton R.E., Yapp P., et al. Excretion of indomethacin in breast milk. J Clin Pharmacol. 32:1991;751-754.
120. Jamali F., Stevens D.R. Naproxen excretion in milk and its uptake by the infant. Drug Intell Clin Pharm. 17:1983;910-911.
121. Brogden R.N., Pinder R.M., Sawyer P.R., Speight T.M., Avery G.S. Naproxen a review of its pharmacological properties and therapeutic efficacy and use . Drugs. 9:1975;326-363.
122. Ostensen M. Piroxicam in human breast milk. Eur J Clin Pharmacol. 25:1983;829-830.
123. Meny R.G., Naumberg E.G., Alger L.S., Brill-Miler J.L., Brown S. Codeine and the breastfed neonate. J Hum Lact. 9:1993;237-240.
124. Marx CM et al: Oxycodone excretion in human milk in the puerperium [Abstract 104]. Drug Intell Clin Pharm 1996;474
125. Steer P.L., Biddle C.J., Marley W.S., Lantz R.K., Sulik P.L. Concentration of fentanyl in colostrum after an analgesic dose. Can J Anaesth. 39:1992;231-235.
126. Leuschen M.P., Wolf L.J., Rayburn W.F. Fentanyl excretion in breast milk. Clin Pharmacol. 9:1990;336-337.
127. Kunka R.L., Venkataramanan R., Stern R.M., Ladik C.F. Excretion of propoxyphene and norpropoxyphene in breast milk. Clin Pharmacol Ther. 35:1984;675-680.
128. Kunka R.L., Yong C.L., Ladik C.F., Bates T.R. Liquid chromatographic determination of propoxyphene and norpropoxyphene in plasma and breast milk. J Pharmacol Sci. 74:1985;103-104.
129. Wittels B., Glosten B., Faure E.A., et al. Postcesarean analgesia with both epidural morphine and intravenous patient-controlled analgesia neurobehavioral outcomes among nursing neonates . Anesth Analg. 85:1997;600-606.
130. Wischnik A., Manth S.M., Lloyd J., Bullingham R., Thompson J.S. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing. Eur J Clin Pharmacol. 36:1989;521-524.